{
    "2021-06-17": [
        [
            {
                "time": "",
                "original_text": "2款新药同时获NMPA批准上市，来自恒瑞、罗氏",
                "features": {
                    "keywords": [
                        "新药",
                        "NMPA",
                        "恒瑞",
                        "罗氏"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "重磅！国家药监局批准2款1类新药上市",
                "features": {
                    "keywords": [
                        "重磅",
                        "国家药监局",
                        "1类新药"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【重磅】“创新药一哥”1类新药获批，对飚超30亿大品种",
                "features": {
                    "keywords": [
                        "重磅",
                        "创新药",
                        "1类新药",
                        "30亿大品种"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "又要募资25亿港元！这家手握首款国产PD-1单抗的公司该如何突围？",
                "features": {
                    "keywords": [
                        "募资",
                        "25亿港元",
                        "PD-1单抗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药董事长：靶点同质化严重是创新药企的一大挑战",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "靶点同质化",
                        "挑战"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "江苏区域股市周报：新增2家上市公司 33家机构调研亚威股份",
                "features": {
                    "keywords": [
                        "江苏区域",
                        "上市公司",
                        "亚威股份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "区域经济",
                        "制造业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "科伦药业转型创新药8年无“实效”，分拆川宁上市为“甩包袱”？",
                "features": {
                    "keywords": [
                        "科伦药业",
                        "创新药",
                        "分拆",
                        "川宁"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国家药监局批准恒瑞医药海曲泊帕乙醇胺片上市",
                "features": {
                    "keywords": [
                        "国家药监局",
                        "恒瑞医药",
                        "海曲泊帕乙醇胺片"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额减少69.57亿元（6月16日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药板块相对估值位于历史中等水平 关注两条主线",
                "features": {
                    "keywords": [
                        "医药板块",
                        "相对估值",
                        "历史中等水平",
                        "关注主线"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}